Influence of lipopolysaccharide on the uterine contraction inhibitory effects of tocolytic agents in pregnant mice

Noboru Sugawara, Toshiaki Okawa, Hidenori Takahashi, Akira Sato, Yuri P. Vedernikov, George Saade, Robert E. Garfield

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The study was undertaken to investigate the influence of lipopolysaccharide (LPS) on the uterine contraction inhibitory effects of tocolytic agents such as ritodrine, magnesium, and diethylamine/nitric oxide (DEA/NO), and on prostaglandin (PG) E2 and nitric oxide (NO) metabolite (NOx) production in pregnant mice at midgestation. Pregnant C57BL mice on day 14 of gestation were sacrificed 6 hours after intraperitoneal injection of LPS (400 μg/kg) or vehicle. Uterine rings were equilibrated in Krebs-Henseleit solution (37°C) bubbled with 20% O2 and 5% CO2 (pH ∼7.4) for sampling and isometric tension recording. The concentration levels of PGE2 and NOx in the solution were determined. Changes of spontaneous contractile activity in response to cumulative concentrations of ritodrine, magnesium, and the NO donor, DEA/NO, from the baseline were determined. Integral contractile activity over 10 minutes at each concentration was calculated and expressed as percentage change from basal activity. Statistical analysis was performed using one-way analysis of variance (ANOVA) followed by the Dunnett test (significance: p < 0.05). LPS treatment significantly increased the production levels of PGE2 and NOx (from 66.8 ± 6.7 pg/g tissue to 147.0 ± 29.0, from 51.0 ± 5.4 pmol/2 μL/g tissue to 98.0 ± 16.2, respectively), p < 0.05). Ritodrine, magnesium, and DEA/NO inhibited spontaneous contractions concentration dependently in uterine rings from both LPS-treated and -untreated animals. Treatment with LPS significantly attenuated the maximal inhibition induced by DEA/NO in uterine rings from pregnant mice. LPS significantly suppressed the uterine contraction inhibitory effects of ritodrine at 10 -8 M concentrations and of magnesium at 4.2 mmol concentration (p < 0.05). We concluded that the effects of ritodrine and magnesium may be reduced under inflammatory conditions because LPS increases the production levels of PGE2 and NOx, which cause increased spontaneous contractions of the uterine myometrium. Therefore, when uterine contractions are not controlled by tocolytics in pregnant patients with preterm labor associated with inflammation, labor induction or pregnancy termination may become significant options in clinical practice.

Original languageEnglish (US)
Pages (from-to)557-562
Number of pages6
JournalAmerican Journal of Perinatology
Volume24
Issue number9
DOIs
StatePublished - Oct 2007

Fingerprint

Tocolytic Agents
Uterine Contraction
Ritodrine
Lipopolysaccharides
Nitric Oxide
Dinoprostone
Magnesium
Magnesium Oxide
Induced Labor
Pregnancy
Nitric Oxide Donors
Myometrium
Premature Obstetric Labor
Intraperitoneal Injections
Inbred C57BL Mouse
Analysis of Variance
Inflammation
diethylamine
Therapeutics

Keywords

  • Contractility
  • Lipopolysaccharides
  • Magnesium
  • Myometrium
  • Nitric oxide
  • PGE2
  • Ritodrine

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Influence of lipopolysaccharide on the uterine contraction inhibitory effects of tocolytic agents in pregnant mice. / Sugawara, Noboru; Okawa, Toshiaki; Takahashi, Hidenori; Sato, Akira; Vedernikov, Yuri P.; Saade, George; Garfield, Robert E.

In: American Journal of Perinatology, Vol. 24, No. 9, 10.2007, p. 557-562.

Research output: Contribution to journalArticle

Sugawara, Noboru ; Okawa, Toshiaki ; Takahashi, Hidenori ; Sato, Akira ; Vedernikov, Yuri P. ; Saade, George ; Garfield, Robert E. / Influence of lipopolysaccharide on the uterine contraction inhibitory effects of tocolytic agents in pregnant mice. In: American Journal of Perinatology. 2007 ; Vol. 24, No. 9. pp. 557-562.
@article{984b6c921c4c4151a564b0ea84744b35,
title = "Influence of lipopolysaccharide on the uterine contraction inhibitory effects of tocolytic agents in pregnant mice",
abstract = "The study was undertaken to investigate the influence of lipopolysaccharide (LPS) on the uterine contraction inhibitory effects of tocolytic agents such as ritodrine, magnesium, and diethylamine/nitric oxide (DEA/NO), and on prostaglandin (PG) E2 and nitric oxide (NO) metabolite (NOx) production in pregnant mice at midgestation. Pregnant C57BL mice on day 14 of gestation were sacrificed 6 hours after intraperitoneal injection of LPS (400 μg/kg) or vehicle. Uterine rings were equilibrated in Krebs-Henseleit solution (37°C) bubbled with 20{\%} O2 and 5{\%} CO2 (pH ∼7.4) for sampling and isometric tension recording. The concentration levels of PGE2 and NOx in the solution were determined. Changes of spontaneous contractile activity in response to cumulative concentrations of ritodrine, magnesium, and the NO donor, DEA/NO, from the baseline were determined. Integral contractile activity over 10 minutes at each concentration was calculated and expressed as percentage change from basal activity. Statistical analysis was performed using one-way analysis of variance (ANOVA) followed by the Dunnett test (significance: p < 0.05). LPS treatment significantly increased the production levels of PGE2 and NOx (from 66.8 ± 6.7 pg/g tissue to 147.0 ± 29.0, from 51.0 ± 5.4 pmol/2 μL/g tissue to 98.0 ± 16.2, respectively), p < 0.05). Ritodrine, magnesium, and DEA/NO inhibited spontaneous contractions concentration dependently in uterine rings from both LPS-treated and -untreated animals. Treatment with LPS significantly attenuated the maximal inhibition induced by DEA/NO in uterine rings from pregnant mice. LPS significantly suppressed the uterine contraction inhibitory effects of ritodrine at 10 -8 M concentrations and of magnesium at 4.2 mmol concentration (p < 0.05). We concluded that the effects of ritodrine and magnesium may be reduced under inflammatory conditions because LPS increases the production levels of PGE2 and NOx, which cause increased spontaneous contractions of the uterine myometrium. Therefore, when uterine contractions are not controlled by tocolytics in pregnant patients with preterm labor associated with inflammation, labor induction or pregnancy termination may become significant options in clinical practice.",
keywords = "Contractility, Lipopolysaccharides, Magnesium, Myometrium, Nitric oxide, PGE2, Ritodrine",
author = "Noboru Sugawara and Toshiaki Okawa and Hidenori Takahashi and Akira Sato and Vedernikov, {Yuri P.} and George Saade and Garfield, {Robert E.}",
year = "2007",
month = "10",
doi = "10.1055/s-2007-986690",
language = "English (US)",
volume = "24",
pages = "557--562",
journal = "American Journal of Perinatology",
issn = "0735-1631",
publisher = "Thieme Medical Publishers",
number = "9",

}

TY - JOUR

T1 - Influence of lipopolysaccharide on the uterine contraction inhibitory effects of tocolytic agents in pregnant mice

AU - Sugawara, Noboru

AU - Okawa, Toshiaki

AU - Takahashi, Hidenori

AU - Sato, Akira

AU - Vedernikov, Yuri P.

AU - Saade, George

AU - Garfield, Robert E.

PY - 2007/10

Y1 - 2007/10

N2 - The study was undertaken to investigate the influence of lipopolysaccharide (LPS) on the uterine contraction inhibitory effects of tocolytic agents such as ritodrine, magnesium, and diethylamine/nitric oxide (DEA/NO), and on prostaglandin (PG) E2 and nitric oxide (NO) metabolite (NOx) production in pregnant mice at midgestation. Pregnant C57BL mice on day 14 of gestation were sacrificed 6 hours after intraperitoneal injection of LPS (400 μg/kg) or vehicle. Uterine rings were equilibrated in Krebs-Henseleit solution (37°C) bubbled with 20% O2 and 5% CO2 (pH ∼7.4) for sampling and isometric tension recording. The concentration levels of PGE2 and NOx in the solution were determined. Changes of spontaneous contractile activity in response to cumulative concentrations of ritodrine, magnesium, and the NO donor, DEA/NO, from the baseline were determined. Integral contractile activity over 10 minutes at each concentration was calculated and expressed as percentage change from basal activity. Statistical analysis was performed using one-way analysis of variance (ANOVA) followed by the Dunnett test (significance: p < 0.05). LPS treatment significantly increased the production levels of PGE2 and NOx (from 66.8 ± 6.7 pg/g tissue to 147.0 ± 29.0, from 51.0 ± 5.4 pmol/2 μL/g tissue to 98.0 ± 16.2, respectively), p < 0.05). Ritodrine, magnesium, and DEA/NO inhibited spontaneous contractions concentration dependently in uterine rings from both LPS-treated and -untreated animals. Treatment with LPS significantly attenuated the maximal inhibition induced by DEA/NO in uterine rings from pregnant mice. LPS significantly suppressed the uterine contraction inhibitory effects of ritodrine at 10 -8 M concentrations and of magnesium at 4.2 mmol concentration (p < 0.05). We concluded that the effects of ritodrine and magnesium may be reduced under inflammatory conditions because LPS increases the production levels of PGE2 and NOx, which cause increased spontaneous contractions of the uterine myometrium. Therefore, when uterine contractions are not controlled by tocolytics in pregnant patients with preterm labor associated with inflammation, labor induction or pregnancy termination may become significant options in clinical practice.

AB - The study was undertaken to investigate the influence of lipopolysaccharide (LPS) on the uterine contraction inhibitory effects of tocolytic agents such as ritodrine, magnesium, and diethylamine/nitric oxide (DEA/NO), and on prostaglandin (PG) E2 and nitric oxide (NO) metabolite (NOx) production in pregnant mice at midgestation. Pregnant C57BL mice on day 14 of gestation were sacrificed 6 hours after intraperitoneal injection of LPS (400 μg/kg) or vehicle. Uterine rings were equilibrated in Krebs-Henseleit solution (37°C) bubbled with 20% O2 and 5% CO2 (pH ∼7.4) for sampling and isometric tension recording. The concentration levels of PGE2 and NOx in the solution were determined. Changes of spontaneous contractile activity in response to cumulative concentrations of ritodrine, magnesium, and the NO donor, DEA/NO, from the baseline were determined. Integral contractile activity over 10 minutes at each concentration was calculated and expressed as percentage change from basal activity. Statistical analysis was performed using one-way analysis of variance (ANOVA) followed by the Dunnett test (significance: p < 0.05). LPS treatment significantly increased the production levels of PGE2 and NOx (from 66.8 ± 6.7 pg/g tissue to 147.0 ± 29.0, from 51.0 ± 5.4 pmol/2 μL/g tissue to 98.0 ± 16.2, respectively), p < 0.05). Ritodrine, magnesium, and DEA/NO inhibited spontaneous contractions concentration dependently in uterine rings from both LPS-treated and -untreated animals. Treatment with LPS significantly attenuated the maximal inhibition induced by DEA/NO in uterine rings from pregnant mice. LPS significantly suppressed the uterine contraction inhibitory effects of ritodrine at 10 -8 M concentrations and of magnesium at 4.2 mmol concentration (p < 0.05). We concluded that the effects of ritodrine and magnesium may be reduced under inflammatory conditions because LPS increases the production levels of PGE2 and NOx, which cause increased spontaneous contractions of the uterine myometrium. Therefore, when uterine contractions are not controlled by tocolytics in pregnant patients with preterm labor associated with inflammation, labor induction or pregnancy termination may become significant options in clinical practice.

KW - Contractility

KW - Lipopolysaccharides

KW - Magnesium

KW - Myometrium

KW - Nitric oxide

KW - PGE2

KW - Ritodrine

UR - http://www.scopus.com/inward/record.url?scp=35448942318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35448942318&partnerID=8YFLogxK

U2 - 10.1055/s-2007-986690

DO - 10.1055/s-2007-986690

M3 - Article

C2 - 17907072

AN - SCOPUS:35448942318

VL - 24

SP - 557

EP - 562

JO - American Journal of Perinatology

JF - American Journal of Perinatology

SN - 0735-1631

IS - 9

ER -